GH Optimization Stack
Maximum GH release with high selectivity
How This Stack Works
CJC-1295 is a GHRH analogue that amplifies GH pulse amplitude — essentially making each natural GH pulse bigger. Ipamorelin is a selective GHRP that triggers GH release without raising cortisol, prolactin, or ACTH. Combined, their GH pulse amplitude is 2–10× higher than either peptide alone, while maintaining the selectivity and safety profile that makes this stack widely favoured in GH optimization protocols.
Why This Combination Works
CJC-1295 and Ipamorelin operate on different receptors — GHRH-R and ghrelin/GHSR-1a respectively. This means they are additive, not redundant. CJC-1295 loads the pituitary and amplifies the signal; Ipamorelin pulls the trigger. Neither causes the side effects associated with synthetic GH — no water retention spikes, no insulin resistance, no cortisol elevation. This makes the stack not only more effective than either alone, but cleaner in its hormonal profile.
Benefits in Detail
Amplified GH Pulse Amplitude
Clinical data shows CJC-1295 alone can increase GH levels 2–10× above baseline. Ipamorelin adds an independent pulse trigger. When combined, the synergistic effect on GH secretion is greater than the sum of parts — delivering sustained GH elevation across the dosing window.
Fat Loss & Body Recomposition
Elevated GH directly stimulates lipolysis — the breakdown of stored fat for energy. Combined with the lean-mass preserving effects of Ipamorelin, this stack is among the most studied for simultaneous fat loss and muscle preservation without the catabolic risks of caloric restriction alone.
Enhanced Muscle Growth
GH stimulates IGF-1 production in the liver, which drives satellite cell activation and muscle protein synthesis. Higher GH pulses translate directly into elevated IGF-1 and the downstream anabolic effects researchers associate with youthful GH status.
Improved Sleep Quality
Natural GH peaks during slow-wave sleep. By amplifying the GH pulse at sleep onset, this stack reinforces the biological relationship between sleep architecture and recovery. Users in protocol studies commonly report deeper, more restorative sleep within the first 2–3 weeks.
No Cortisol or Prolactin Elevation
Unlike GHRP-2 or GHRP-6, Ipamorelin does not stimulate cortisol or prolactin release at therapeutic doses. This selectivity is a primary reason this stack is preferred over older GH peptide protocols — all the anabolic benefit, none of the stress hormone elevation.
Skin & Connective Tissue Benefits
GH plays a central role in collagen synthesis and skin elasticity. Restored GH signalling through this stack has been associated with improvements in skin thickness, joint lubrication, and overall connective tissue quality — particularly relevant in anti-aging protocols.
Protocol
CJC-1295 (no DAC): 100–200 mcg subcutaneous. Ipamorelin: 200–300 mcg subcutaneous. Administer both together 2–3× per week, ideally before sleep when natural GH pulses peak.
For laboratory use only. Not for human consumption.
Expected Timeline
Weeks 1–3
Priming
GH pulse amplitude begins increasing. Sleep improvements often noticed first. Mild increases in hunger are common.
Weeks 4–8
Active Response
Body composition changes become measurable. Increased muscle fullness, reduced subcutaneous fat. IGF-1 levels peak.
Weeks 9–16
Consolidation
Sustained body recomposition continues. Skin and connective tissue improvements become visible. Cycle break recommended after 16 weeks.
Who Is This Stack For?
Researchers studying GH secretagogue protocols, body composition optimisation, anti-aging interventions, or sleep quality enhancement.
For Laboratory Use Only: All information is for educational purposes. Not medical advice. Not for human consumption. Consult a qualified physician before any use.
Source This Stack
Ready to Order the GH Optimization Stack?
CJC-1295 + Ipamorelin — all available directly from Pantheon Peptides.
Shop All Stack Peptides on Pantheon